D.E. Shaw & Co
GUTS icon

D.E. Shaw & Co’s Fractyl Health GUTS Stock Holding History

D.E. Shaw & Co’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,442,745
Closed -$3.17M – 5147
2025
Q4 		$3.17M Buy
1,442,745
+1,148,455
+390% +$1.85M ﹤0.01% 2684
2025
Q3 		$468K Buy
+294,290
New +$382K ﹤0.01% 3895

Other funds holding GUTS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co's GUTS Position: Q1 2026 in Review

D.E. Shaw & Co sold out of Fractyl Health (GUTS) in Q1 2026, closing a stake of 1,442,745 shares — an estimated $3.17M sold.

D.E. Shaw & Co first reported a position in GUTS in Q3 2025 and held it in 2 quarters. The position peaked at $3.17M in Q4 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • D.E. Shaw & Co reported no remaining Fractyl Health position as of Q1 2026 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,442,745 Fractyl Health shares in Q1 2026, an estimated $3.17M.
  • D.E. Shaw & Co first reported a position in Fractyl Health in Q3 2025 and held it in 2 quarters.
  • D.E. Shaw & Co's Fractyl Health position peaked at $3.17M in Q4 2025.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.